Cargando…

CYP2C19(⁎)2 Polymorphism in Chilean Patients with In-Stent Restenosis Development and Controls

Clopidogrel is an antiplatelet drug especially used in patients undergoing percutaneous coronary interventions (PCI). Polymorphisms within CYP2C19 can result in important interindividual variations regarding therapeutic efficacy. Therefore, we aimed to evaluate the impact of the CYP2C19(⁎)2 variant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruedlinger, Jenny, Prado, Yalena, Zambrano, Tomás, Saavedra, Nicolás, Bobadilla, Braulio, Potthoff, Marcelo, Pérez, Luis, Lanas, Fernando, Salazar, Luis A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530410/ https://www.ncbi.nlm.nih.gov/pubmed/28785581 http://dx.doi.org/10.1155/2017/5783719

Ejemplares similares

Circulating miRNA-23b and miRNA-143 Are Potential Biomarkers for In-Stent Restenosis
por: Saavedra, Nicolás, et al.
Publicado: (2020)

SLCO1B1 c.388A>G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals
por: Prado, Yalena, et al.
Publicado: (2015)

MicroRNA-33b is a Potential Non-Invasive Biomarker for Response to Atorvastatin Treatment in Chilean Subjects With Hypercholesterolemia: A Pilot Study
por: Ubilla, Carmen Gloria, et al.
Publicado: (2021)

The Current State of MicroRNAs as Restenosis Biomarkers
por: Varela, Nelson, et al.
Publicado: (2020)

APOE Polymorphisms Contribute to Reduced Atorvastatin Response in Chilean Amerindian Subjects
por: Lagos, Jenny, et al.
Publicado: (2015)

Cholesterol-Related lncRNAs as Response Predictors of Atorvastatin Treatment in Chilean Hypercholesterolemic Patients: A Pilot Study
por: Paez, Isis, et al.
Publicado: (2023)

Long Non-Coding RNAs Might Regulate Phenotypic Switch of Vascular Smooth Muscle Cells Acting as ceRNA: Implications for In-Stent Restenosis
por: Arencibia, Alberto, et al.
Publicado: (2022)

Atorvastatin Increases the Expression of Long Non-Coding RNAs ARSR and CHROME in Hypercholesterolemic Patients: A Pilot Study
por: Paez, Isis, et al.
Publicado: (2020)

Association of polymorphisms within the Renin-Angiotensin System with metabolic syndrome in a cohort of Chilean subjects
por: Herrera, Christian L., et al.
Publicado: (2016)

Polyphenols from Chilean Propolis and Pinocembrin Reduce MMP-9 Gene Expression and Activity in Activated Macrophages
por: Saavedra, Nicolás, et al.
Publicado: (2016)

Impacts of CYP2C19 Polymorphism and Clopidogrel Dosing on in-Stent Restenosis: A Retrospective Cohort Study in Chinese Patients
por: Zhang, Min, et al.
Publicado: (2020)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
por: Dinesch, Violeta, et al.
Publicado: (2017)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Current Management of In-Stent Restenosis
por: Her, Ae-Young, et al.
Publicado: (2018)

Calcified in-stent restenosis in a venous stent
por: Schmidt, Jens-Ove, et al.
Publicado: (2015)

Hypersensitivity and in-stent restenosis in coronary stent materials
por: Hu, Wansong, et al.
Publicado: (2022)

Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009)

Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Publicado: (2017)

Overlap stenting for in-stent restenosis after carotid artery stenting
por: Nishihori, Masahiro, et al.
Publicado: (2016)

MicroRNA-20a-5p Downregulation by Atorvastatin: A Potential Mechanism Involved in Lipid-Lowering Therapy
por: Saavedra, Kathleen, et al.
Publicado: (2022)

In Stent Restenosis Predictors after Carotid Artery Stenting
por: Cosottini, Mirco, et al.
Publicado: (2010)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
por: Ohri, Nisha, et al.
Publicado: (2015)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Treatment of Femoropopliteal Artery In-stent Restenosis
por: Kim, Wonho, et al.
Publicado: (2018)

Aortoiliac reconstruction in the setting of in-stent restenosis
por: Natraj Setty, H. S., et al.
Publicado: (2017)

ERK1/2 and HIF1α Are Involved in Antiangiogenic Effect of Polyphenols-Enriched Fraction from Chilean Propolis
por: Cuevas, Alejandro, et al.
Publicado: (2015)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

In-stent restenosis and longitudinal stent deformation: a case report
por: Si, Daoyuan, et al.
Publicado: (2020)

Intravascular Imaging for Guiding In‐Stent Restenosis and Stent Thrombosis Therapy
por: Erdogan, Emrah, et al.
Publicado: (2022)

Psychometric Properties of the Maternal and Paternal Parenting Styles Scale in Chilean Adolescents
por: Gálvez-Nieto, José Luis, et al.
Publicado: (2021)

In-stent restenosis and stented-territory infarction after carotid and vertebrobasilar artery stenting
por: Ryu, Jae-Chan, et al.
Publicado: (2023)

Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis
por: Brito, Luis A, et al.
Publicado: (2010)

‘Miracle stents’ - a future without restenosis
por: Hamid, Huda, et al.
Publicado: (2007)

Heavy Coronary Calcium Mimicking In-Stent Restenosis
por: Park, Jeong-Hwan, et al.
Publicado: (2011)

In stent restenosis after percutaneous coronary intervention
por: Eyüboğlu, Mehmet
Publicado: (2016)

Neovascularization in Human Intracranial Atherosclerotic In-Stent Restenosis
por: Feng, Yiding, et al.
Publicado: (2021)

Hyperglycemia Drives Stent Restenosis in STEMI Patients
por: Mone, Pasquale, et al.
Publicado: (2021)

Antibiofilm Activity of Chilean Propolis on Streptococcus mutans Is Influenced by the Year of Collection
por: Veloz, Jorge Jesús, et al.
Publicado: (2015)

Comparison of carotid endarterectomy and repeated carotid angioplasty and stenting for in-stent restenosis (CERCAS trial): a randomised study
por: Hrbáč, Tomáš, et al.
Publicado: (2023)

Enabling Angioplasty‐Ready “Smart” Stents to Detect In‐Stent Restenosis and Occlusion
por: Chen, Xing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aqei6h9evkdq9s8lfqd3328o3u